Active surveillance and response evaluation strategy after neoadjuvant therapy for esophageal cancer
10.3760/cma.j.cn113030-20210118-00029
- VernacularTitle:食管癌新辅助治疗后主动监测及疗效评估策略
- Author:
Yunsong LIU
1
;
Yu MEN
;
Zhouguang HUI
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科，北京 100021
- Keywords:
Esophageal neoplasms;
Active surveillance;
Neoplasm, residual;
Complete response;
Response evaluation
- From:
Chinese Journal of Radiation Oncology
2022;31(9):848-853
- CountryChina
- Language:Chinese
-
Abstract:
A considerable proportion of esophageal carcinoma patients could achieve pathological complete response (pCR) after neoadjuvant therapy, for whom accurate response evaluation and active surveillance rather than surgery-aiming to avoid the complications, mortality and reduced quality of life after surgery-has become a research hotspot. To detect residual disease and predict pCR accurately by appropriate method(s) is the key of active surveillance strategy. In this article, we elaborated the active surveillance strategy of esophageal cancer and characteristics of different evaluation methods in terms of radiology, pathology and combined detection.
